Salinas, Jozen Eli .

HRN: 27-44-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/09/2025
07/15/2025
ORAL
2ml
TID
Amoebiasis; PCAP B
Remove - Pending Acceptance
07/09/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/09/2025
07/15/2025
IVT
200mg
Q6H
Amoebiasis; PCAP B
Remove - Pending Acceptance
07/11/2025
CEFTRIAXONE 1G (VIAL)
07/11/2025
07/18/2025
IV DRIP
250 Mg
Q12h
AGE; PCAP B
Remove - Pending Acceptance
07/12/2025
CEFTRIAXONE 1G (VIAL)
07/12/2025
07/19/2025
IV
400
OD
AGE; PCAP
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: